Comparison of the effect of BCAA granules on between decompensated and compensated cirrhosis

Hepato-Gastroenterology

Volumn 56, Issue 96, 2009, Pages 1719-1723

  Habu, Daiki ^a   Nishiguchi, Shuhei ^a   Nakatani, Shinji ^a   Lee, Chulyoo ^a   Enomoto, Masaru ^a   Tamori, Akihiro ^a   Takeda, Tadashi ^a   Ohfuji, Satoko ^a   Fukushima, Wakaba ^a   Tanaka, Takashi ^a   Kawamura, Etsuji ^a   Shiomi, Susumu ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Branchedchain amino acid; Branchedchain amino acid tyrosine ratio (BTR); LHCV related cirrhosis; Serum albumin level

Indexed keywords

BRANCHED CHAIN AMINO ACID; SERUM ALBUMIN; TYROSINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DECOMPENSATED LIVER CIRRHOSIS; DIET SUPPLEMENTATION; DRUG GRANULE; FEMALE; HEPATITIS C VIRUS; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

AGED; AMINO ACIDS, BRANCHED-CHAIN; FEMALE; HEPATITIS C; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; SERUM ALBUMIN;

EID: 74949085089     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Yoshida T, Muto Y, Moriwaki H, Yamamoto M: Effect of long-term oral supplementation with branched-chain amino acid granules on the prognosis of liver cirrhosis. Gastroenterol Jpn 1989; 24:692-698.
2. Kato M, Miwa Y, Tajika M, Hiraoka T, Muto Y, Moriwaki H: Preferential use of branched-chain amino acid as energy substrate in patients with cirrhosis. Internal Medicine 1998; 37:429-434.
3. Habu D, Nishiguchi S, Enomoto M, et al: Ultrasonographic Diagnosis of Degree of Chronic Type C Liver Disease: Hepatogastroenterology 2002; in press.
4. Azuma Y, Maekawa M, Kuwabara Y, et al: Determination of branched-chain amino acids and tyrosine in serum of patients with various hepatic diseases, and its clinical usefulness. Clin Chem 1989; 35: 1399-1403.
5. Campallo O, Sprengers D, Mclntyre N: The BCAA/AAA ratio of plasma amino acid in three different groups of cirrhotics. Rev Invest Clin 1992; 44: 513-518.
6. Kawamura YN, Kaito M, Nakagawa N, et al: Evaluating response to nutritional therapy using the branched chain amino acid tyrosine ratio in patients with chronic liver disease. J Clin Lab Anal 1999; 13: 31-34.
7. Kohashi T, Itamoto T, Katayama K, et al: Significance of the molar ratio of branched-chain amino acids to tyrosine before hepatectomy. Hepatogastroenterology 2202; 49:774-777.
8. Clemmesen JO, Kondrup J, Ott P: Splanchnic and leg exchange of amino acids and ammonia in acute liver failure. Gastroenterology 2000; 118: 1131-1139.
9. O'Keefe SJD, Abraham R, El-Zayadi A, Marshall W, Davis M, Williams R: Increased plasma tyrosine concentrations in patients with cirrhosis and fulminant hepatic failure associated with increased plasma tyrosine flux and reduced hepatic oxidation capacity. Gastroenterology 1981; 81: 1017-1024.
10. Okuno M, Moriwaki H, Kato M, Muto M, Kojima S: Changes in the ratio of branched- chain to aromatic acids affect the secretion of albumin in cultured rat hepatocytes. Biochem Bioph Res Co 1995; 214:1045-1050.
11. Usui T, Moriwaki H, Hatakeyama H, et al: Oral supplementation with branched-chain amino acid improves transthyretin turnover in rats with carbon tetrachloride-induced liver cirrhosis. J Nutr 1996; 123: 1412-1420.
12. Kajiwara K, Okuno M, Kobayashi T, et al: Oral supplementation with branched-chain amino acid improves survival rate of rats with carbon tetrachloride-induced liver cirrhosis. Dig Dis Sci 1998; 43: 1572-1579.
13. Sugiyama K, Yu LQ, Nagasue N: Direct effect of branched-chain amino acid on the growth and metabolism of cultured human hepatocellular carcinoma cells. Nutritional and Cancer An International Journal 1998; 31: 62-68.
14. Bianchi GP, Marchesini G, Zoli M, Abbiati R, Ferrario A, Pisi E: Oral BCAA supplementation in cirrhosis with chronic encephalopathy: effects on prolactin and estradiol levels. Hepatogastroenterol 1992; 39: 443-446.
15. Tangkijvanich P, Mahachai V, Wittayalerpanya S, Ariyawongsopon V, Isarasena S: Short-term effect of branched-chain amino acid on liver function tests in cirrhotic patients. Southeast Asian J Trop Med Public Health 2000; 31: 152-157.
16. Yamauchi M, Takeda K, Sakamoto K, Ohata M, Toda G: Effect of oral branched chain amino acid supplementation in the late evening on the nutritional state of patients with liver cirrhosis. Hepatol Res 2001; 21: 199-204.
17. Pere G, Enrique Q, Vicente A, et al: Compensated cirrhosis: Natural history and prognostic factors. Hepatology 1987; 7: 122-128.
18. Marco Z, Maria RC, Guulio M, et al: Prognostic indicators in compensated cirrhosis. Am J Gastroenterol 1991; 86: 1508-1513.
19. Reisman Y, Gips CH, Lavelle M, et al: Assessment of liver cirrhosis severity in 1015 patients of Euricterus database with Campbell-Child, Pugh-Child and with ascites and ascites-nutritional state (ANS) related classifications. Hepato-Gastroenterology 1997; 44: 1376-1384.
20. Jerome G, Lawrence S, Anne MB, Olivier C, Renee EP, Raoul P: Prognostic value of serum hyaluronan in patients with compensated HCV cirrhosis. J Hepatol 2000; 32: 447-452.
21. Luo JC, Hwang SJ, Chang FY, et al: Simple blood tests can predict compensated liver cirrhosis in patients with chronic hepatitis C. Hepato-gastroenterology 2002; 49: 478-481.